Advances in the Management of Pancreatic Adenocarcinoma
The approval of therapies indicated for patients with rare mutations and the recommendation for testing all patients with pancreatic cancer has changed the testing and treatment landscape significantly. Health care professionals (HCP) need to be well versed in the potential for actionable mutations and how to counsel patients accordingly.
Category
  • Pancreatic Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Pharmacy Updates: Updates in the Treatment of Pancreatic Adenocarcinoma
Systemic therapy options in metastatic pancreatic cancer are evolving, including increasing usage of maintenance therapies. There is a need to review the current landscape of treatment regimens and have an understanding of their place in therapy.
Category
  • Pancreatic Cancer
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Event date March 11, 2021